Table 1 Patient characteristics (n = 73)
Characteristic | No. | % |
|---|---|---|
Age,years | ||
Median | 49 | |
Range | 33-65 | |
Amenorrhea | ||
Premenopausal | 29 | 39.7 |
Postmenopausal | 44 | 60.3 |
Radical mastectomy | ||
No previous mastectomy | 5 | 6.8 |
Previous mastectomy | 68 | 93.2 |
Time to first relapse, years | ||
Median | 2.55 | |
Range | 0.4-17 | |
No. of metastatic sites | ||
1 | 15 | 20.5 |
2 | 24 | 32.9 |
3 or more | 34 | 46.6 |
Metastatic sites | ||
Visceral | 59 | 80.8 |
Lung | 40 | 54.8 |
Liver | 27 | 37.0 |
Nonvisceral | 14 | 19.2 |
Bone | 23 | 31.5 |
ER status | ||
Positive | 40 | 54.8 |
Negative | 32 | 43.8 |
Unknown | 1 | 1.4 |
PR status | ||
Positive | 33 | 45.2 |
Negative | 38 | 52.1 |
Unknown | 2 | 2.7 |
HER-2 status | ||
Positive | 18 | 24.7 |
Negative | 52 | 71.2 |
Unknown | 3 | 4.1 |
Lines of chemotherapy | ||
First line | 36 | 49.3 |
Second line | 28 | 38.4 |
Third or more | 9 | 12.3 |
Prior chemotherapy | ||
Adjuvant/neoadjuvant (n = 68) | ||
Anthracycline containing | 53 | 72.6 |
Taxane containing | 34 | 50.0 |
Both | 27 | 39.7 |
Chemotherapy for MBC (n = 37) | ||
Anthracycline containing | 6 | 16.2 |
Taxane containing | 12 | 32.4 |
Both | 3 | 8.1 |